Etienne Garin

Prof. Dr. Etienne Garin

Nuclear Medicine, Centre Eugène Marquis, Rennes, Bretagne, France

Biography

Prof Etienne Garin specializes in nuclear medicine. He has worked at the Cancer Institute Eugène Marquis of Rennes, France, since 1997 and belongs to the research team U1317 of the National Institute of Medical Research. He obtained an MD degree and nuclear medicine specialization degree in 1997 at Rennes 1 University, France. He obtained his PhD degree in 2004 on the development of a new compound for radioembolization, 188Re-SSS lipiodol. He has been a Professor of the University of Rennes 1 since 2007. He has more than 20 years of experience with radioembolization. His research activity is focused on radioembolization of primary hepatic tumors with numerous studies using 131I lipiodol in the past and currently 90Yttrium-labeled microspheres. He has carried out many studies regarding dosimetry and is fully involved in personalised dosimetry development. He has about 80 international publications on radioembolization. He is currently co-PI of the TARGET trial (international retrospective multicentric study about 90Yttrium glass microsphere dosimetry) and of the French registry study Proactif in HCC. He has been the global PI of the randomized multicenter IIS study DOSISPHERE-01 evaluating the standard dosimetric approach versus a personalized one. He was the PI of the Lip-Re-1 study and is PI of the ongoing Lip-Re-2 trial. He is a member of the French Society of Biophysics and Nuclear Medicine and of the European Association of Nuclear Medicine.

Affiliations

Centre Eugène Marquis

Rennes, Bretagne, France

Nuclear Medicine

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.